OS THERAPIES

OS Therapies (OST) is a clinical-stage therapeutics company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet the significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, they are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years.